Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection.
about
Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhoodPPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional studyRegional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease.rs7903146 polymorphism at transcription factor 7 like 2 gene is associated with total cholesterol and lipoprotein profile in HIV/hepatitis C virus-coinfected patients.Chronic noncommunicable diseases and HIV-AIDS on a collision course: relevance for health care delivery, particularly in low-resource settings--insights from South AfricaInfluences of gender in metabolic syndrome and its components among people living with HIV virus using antiretroviral treatment in Hawassa, southern Ethiopia.Special populations and pharmacogenetic issues in tuberculosis drug development and clinical researchDiagnosis and management of common chronic metabolic complications in HIV-infected patients.Histopathological Changes of the Thyroid and Parathyroid Glands in HIV-Infected Patients.Metabolic complications associated with antiretroviral therapy in HIV-infected and HIV-exposed uninfected paediatric patients.Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.Analysis of the prevalence of dyslipidemia in individuals with HIV and its association with antiretroviral therapy.Lipodystrophy syndrome in HIV treatment-multiexperienced patients: implication of resistin.IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients.The heart of the matter: cardiometabolic care in youth with psychosis.Association of adiponectin (ADIPOQ) rs2241766 polymorphism and dyslipidemia in HIV/HCV-coinfected patients
P2860
Q33665359-C79FC185-75FC-47CD-8903-7711E3C60EF1Q33849136-3D097546-018E-4DE5-A1D5-7A361A6576C7Q34495072-A74DBC2C-219C-4E57-84B8-8AEE83212F63Q34803775-D304AB33-518A-4FA0-ADA2-6727AB5CE371Q34946422-BD92F683-9E31-4C41-81DF-C6CF6E92A149Q35142495-86F01275-B815-47A8-9301-30EB8133A525Q35578696-84FC7116-7766-4EE8-BCC2-B7C996A25980Q35946656-F42EBEB0-1DED-4046-B314-639125CC1A90Q36000004-7E91013C-10F0-42DF-932F-D7E505E8CF7DQ37329874-29A24882-73CB-4C63-86E8-057E68F0DAA9Q37577247-86708DDE-D3E1-4465-9EFF-ECDAB7728FD6Q37676229-B7A25A29-FEDE-4973-831C-45420FA61202Q38109095-17630365-19A2-4A08-8E0D-930A8BB26BFFQ41623039-08145663-712B-46DD-AE7D-D6BD19E9AF81Q42228156-89509E92-E2E6-464D-827A-269D13D1ABDBQ42242609-937FBF0B-9E4B-4C60-8CAD-BC2DEE7F878EQ50773906-B6144F58-7731-42E4-B29E-810977B52914Q57897461-67F8C301-065F-47C9-B0A8-349D2AB83DF0
P2860
Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic consequences and the ...... odeficiency virus-1 infection.
@en
Metabolic consequences and the ...... odeficiency virus-1 infection.
@nl
type
label
Metabolic consequences and the ...... odeficiency virus-1 infection.
@en
Metabolic consequences and the ...... odeficiency virus-1 infection.
@nl
prefLabel
Metabolic consequences and the ...... odeficiency virus-1 infection.
@en
Metabolic consequences and the ...... odeficiency virus-1 infection.
@nl
P356
P1476
Metabolic consequences and the ...... odeficiency virus-1 infection.
@en
P2093
Katherine Samaras
P304
P356
10.1093/JAC/DKM475
P407
P577
2007-12-10T00:00:00Z